2024 Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Global Market Report by Medical 007
2024 Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Global Market Report by Medical 007
Introduction
With the continuous advancement of technology and the increase in market demand, the radiotherapy and radiopharmaceuticals market will continue to expand. It is expected that by 2029, the radiopharmaceutical market will reach US$21.03 billion, while the radiotherapy products and services market will reach US$10.22 billion. Radiotherapy and radiopharmaceuticals play an increasingly important role in modern medicine. As the incidence of cancer and other chronic diseases continues to rise, the demand for these treatments is also increasing.
Radiotherapy and radiopharmaceuticals play an increasingly important role in modern medicine. As the incidence of cancer and other chronic diseases continues to rise, the demand for these treatments is also increasing. According to the latest report “HLC176E: Global Market for Radiotherapy, Radiopharmaceuticals and Nuclear Medicine”, we can gain insight into the market dynamics, drivers, challenges and future development trends in these fields.
Market Overview
In 2023, the global radiotherapy products and radiopharmaceuticals market was valued at US$16.1 billion and is expected to grow to US$31.3 billion by 2029, with a compound annual growth rate (CAGR) of 12.3%. This growth is mainly driven by the rising incidence of cancer and other chronic diseases, the emphasis on early screening and diagnosis, and the trend of precision medicine.
Market Drivers
Rising cancer incidence: Cancer is one of the leading causes of death worldwide, and it is expected that by 2045, the number of new cancer cases worldwide will reach 31 million per year. This directly drives the demand for radiotherapy and radiopharmaceuticals.
Early screening and diagnosis: With the emphasis on early detection of cancer, radiotherapy is becoming more and more widely used in early cancer treatment.
Technological advances in radiotherapy planning and delivery systems: Advanced imaging technology and treatment planning software have improved the precision and effectiveness of radiotherapy.
Increasing demand in developing countries: With the increase in healthcare spending and the improvement of medical infrastructure, the demand for radiotherapy equipment in developing countries is growing rapidly.
Market Challenges
Shortage of professional talents: Radiotherapy is a highly specialized field that requires a large number of well-trained professionals such as radiation oncologists, physicists and radiation therapists.
Manufacturing and supply chain issues: The production and supply of radiopharmaceuticals involve complex logistics and strict regulatory requirements, which poses challenges to supply chain management.
Infrastructure and professional imaging equipment requirements: Advanced imaging equipment such as PET and SPECT scanners require a lot of capital investment and operating costs, which to some extent limits the application of nuclear medicine technology.
Market Trends
Precision Medicine: Radiopharmaceuticals play an increasingly important role in precision medicine, such as identifying biomarkers through nuclear imaging technology, enabling early disease detection and personalized treatment.
Emerging technologies in radiopharmaceuticals: Such as targeted alpha therapy and PET/MRI hybrid imaging technology, are changing the development and application of radiopharmaceuticals.
Emerging technologies in radiotherapy: Such as the application of artificial intelligence (AI) in radiotherapy, it improves the efficiency of diagnosis, treatment plan optimization and dose delivery.
Market Segmentation
The report analyzes the different segments of the radiotherapy market and radiopharmaceutical market in detail. The radiotherapy market is segmented by product type, technology type, technology, system type, application and region. The radiopharmaceutical market is segmented by product type, application, production method and region.
Competitive Intelligence
The report also covers radiotherapy equipment manufacturers and leading companies in the field of radiopharmaceuticals. For example, Siemens Healthineers, Elekta AB and Accuray Inc. are major players in the radiotherapy equipment market. Cardinal Health, Curium, GE Healthcare, and Lantheus are the major companies in the radiopharmaceutical market.
Future Outlook
With the continuous advancement of technology and the increase in market demand, the radiotherapy and radiopharmaceutical market will continue to expand. It is expected that by 2029, the radiopharmaceutical market will reach US$21.03 billion, while the radiotherapy products and services market will reach US$10.22 billion. This growth will provide huge opportunities for related companies and investors.
In summary, this report provides us with a comprehensive perspective on the current status and future trends of the radiotherapy and radiopharmaceutical market. With the continuous advancement of medical technology and the increasing aging of the global population, these treatments will play an increasingly important role in the treatment of cancer and other chronic diseases.
Image
Report Highlights The global market for radiotherapy products and radiopharmaceuticals is expected to grow from US$17.5 billion in 2024 to US$31.3 billion by the end of 2029, with a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
The report includes 51 data tables and 39 additional tables Overview of the global radiotherapy, radiopharmaceuticals and nuclear medicine market Analysis of global market trends, including historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2025, and projected CAGR for 2029 Identification of new opportunities, challenges, and technological changes in the industry, with market share analysis by segment, product type, technology type, application, production method, and region Review of companies’ current and future market strategies, including radiopharmaceuticals for diagnostic and therapeutic purposes Exploration of applications for positron emission tomography (PET) and single photon emission computed tomography (SPECT) Market opportunity assessment for external radiation therapy, internal radiation therapy, and systemic radiation therapy Analysis of current market trends and forecasts, R&D activities, product launches, and regulatory elements Analysis of market share, mergers and acquisitions, joint ventures, and collaborations of major companies Profiles of key players in the market, including Aquapharm, Cardinal Health, Elekta, Novartis, and Siemens Healthineers
Report Scope This report analyzes the global market for radiotherapy products (systems, software, and services) and radiopharmaceuticals in terms of quantitative and qualitative data to help readers develop assessment markets, business/growth strategies, and make informed business decisions regarding radiotherapy products and services, and radiopharmaceuticals. BCC Research estimates market data for 2023 (base year) and forecasts values from 2024 to 2029. Radiotherapy market segmentation is based on product, technology, process, system type, application, and region. Radiopharmaceuticals market segmentation is based on product, application, production method, and region. Industry growth drivers, restraints, and opportunities for the radiotherapy and radiopharmaceuticals market are also discussed. The report also reports on the competitive landscape of radiotherapy products, radiopharmaceuticals market, and emerging trends. The latest new products, acquisitions, and collaborations related to the radiotherapy and radiopharmaceuticals market are also covered.
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Market August 2024
Table of Contents
Chapter 1: Executive Summary
Market Outlook
Report Scope
Market Summary
Chapter 2: Market Overview
4. Radiopharmaceuticals
5. Radiotherapy
Chapter 3: Market Dynamics
7. Radiotherapy Market Drivers
8. Rising Prevalence of Cancer
9. Early Screening
9. Advances in Radiotherapy Planning and Delivery Systems
9. Increasing Demand in Developing Countries
11. Radiotherapy Market Restraints
11. Shortage of Technical Professionals
11. Limited Effectiveness in Metastatic Cancer
11. Radiotherapy Market Trends
11. Increasing Use of Advanced Imaging and Fractionated Radiotherapy
12. Adaptive Radiotherapy
12. Radiopharmaceutical Market Drivers
12. Rising Prevalence of Chronic Diseases
12. Focus on Early Diagnosis and Screening
13. Precision Medicine
13. Nuclear Imaging Technologies
13. Increasing Investments
15. Radiopharmaceutical Market Restraints
15. Production and Supply Chain Issues
16. Infrastructure and Dedicated Imaging Equipment Requirements
16. Radiopharmaceutical Market Trends
16. Theranostics
16. PET/MRI Hybrid Imaging
Chapter 4: Emerging Technologies and Developments
17. Emerging Technologies in Radiotherapy
17. Artificial Intelligence
18. Online Adaptive Radiotherapy
18. MR-Linac
19. FLASH Radiotherapy
20. Emerging Technologies in Radiopharmaceuticals
20. Targeted Alpha Therapy
Chapter 5: Market Segment Analysis
21. Segment Breakdown
21. Radiotherapy Market by Product Type
21. Market Overview
22. Market Size and Forecast
24. Radiotherapy Market by Technology Type
24. Market Size and Forecast
25. External Beam Radiotherapy
25. EBRT by Technology Type
30. EBRT by System Type
35. EBRT by Application
38. Internal Beam Radiotherapy
38. IBRT by Technology Type
41. IBRT by Product Type
44. IBRT by Application
47. Radiotherapy Market by Region
47. Market Size and Forecast
49. North America
51. Europe
53. Asia Pacific
56. Rest of the World (Row)
Radiopharmaceutical Market by Product Type
Market Size and Forecast
Diagnostic Radiopharmaceuticals
Therapeutic Radiopharmaceuticals
Radiopharmaceuticals Market by Application
Market Size and Forecast
Oncology
Cardiology
Neurology
Other Applications
Radiopharmaceuticals Market by Production Method
Market Overview
Nuclear Reactors
Cyclotrons
Radionuclide Generators
Market Size and Forecast
Radiopharmaceuticals Market by Region
Market Size and Forecast
North America
Europe
Asia Pacific
Chapter 6: Competitive Intelligence
85. Major Radiotherapy Equipment Manufacturers
86. Leading Companies in the Radiopharmaceutical Sector
Appendix
88. Methodology
88. Sources
88. Abbreviations
89. Company Profiles
